Healthcare - Biotechnology - NASDAQ - US
$ 2.53
-1.17 %
$ 73 M
Market Cap
-0.81
P/E
Price Target
Average
927.67%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
29.22%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Aerovate Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for AVTE of $26 , with forecasts ranging from a low of $2 to a high of $65 .
AVTE Lowest Price Target
Wall Street Target
2 USD
-20.95%
AVTE Average Price Target
Wall Street Target
26 USD
927.67%
AVTE Highest Price Target
Wall Street Target
65 USD
2469.17%
REVENUE FORECAST
Revenue Forecast Chart AVTE
EBIT FORECAST
EBIT Forecast Chart AVTE
NET INCOME FORECAST
Net Income Chart AVTE